RMIT University
Browse

Immunogenicity of a tripartite cell penetrating peptide containing a MUC1 variable number of tandem repeat (VNTR) and a T helper epitope

journal contribution
posted on 2024-11-02, 08:26 authored by Nicole Brooks, Jennifer Hsu, S Esparon, Dodie PouniotisDodie Pouniotis, Geoffrey Pietersz
Peptide-based vaccines for cancer have many advantages however, for optimization these immunogens should incorporate peptide epitopes that induce CD8, as well as CD4 responses, antibody and long term immunity. Cell penetrating peptides (CPP) with a capacity of cytosolic delivery have been used to deliver antigenic peptides and proteins to antigen presenting cells to induce cytotoxic T cell, helper T cell and humoral responses in mice. For this study, a tripartite CPP including a mucin 1 (MUC1) variable number of tandem repeat (VNTR) containing multiple T cell epitopes and tetanus toxoid universal T helper epitope peptide (tetCD4) was synthesised (AntpMAPMUC1tet) and immune responses investigated in mice. Mice vaccinated with AntpMAPMUC1tet + CpG show enhanced antigen-specific interferon-gamma (IFN-γ) and IL-4 T cell responses compared with AntpMAPMUC1tet vaccination alone and induced a Th1 response, characterised by a higher ratio of IgG2a antibody/IgG1 antibodies. Furthermore, vaccination generated long term MUC1-specific antibody and T cell responses and delayed growth of MUC1+ve tumours in mice. This data demonstrates the efficient delivery of branched multiple antigen peptides incorporating CPP and that the addition of CpG augments immune responses.

History

Related Materials

  1. 1.
    DOI - Is published in 10.3390/molecules23092233
  2. 2.
    ISSN - Is published in 14203049

Journal

Molecules

Volume

23

Number

2233

Issue

9

Start page

1

End page

21

Total pages

21

Publisher

MDPIAG

Place published

Switzerland

Language

English

Copyright

© 2018 by the authors. Creative Commons Attribution (CC BY) license

Former Identifier

2006087997

Esploro creation date

2020-06-22

Fedora creation date

2019-03-26